https://orcid.org/0000-0001-9907-3522
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lei Sun, Hong Zhao, Xiao-Yan Ding, Kun Yang, Gui-Shuang Wang, Jia-Min Chen, Xiao-Yi Han, Gang Wan, Liang Zhang, Xin-Gang Zhou, Xiang-Mei Chen, Peng Wang & Wen Xie. (2023) Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors. Journal of Hepatocellular Carcinoma 10, pages 833-846.
Read now
Read now
Jaime Calvo Alén, Bernardo Alio Lavin-Gomez, Elena Aurrecoechea, Armando Raul Guerra Ruiz, Víctor Martínez Taboada & Juan Gómez Gerique. (2022) TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients. Biologics: Targets and Therapy 16, pages 187-197.
Read now
Read now
Articles from other publishers (27)
Yuyao Qiu, Wen Hao, Yingying Guo, Qian Guo, Yushi Zhang, Xiaochen Liu, Xiao Wang & Shaoping Nie. (2023) The association of lipoprotein (a) with coronary artery calcification: A systematic review and meta-analysis. Atherosclerosis, pages 117405.
Crossref
Crossref
Nicole Ciffone, Catherine J. McNeal, Mary P. McGowan & Keith C. Ferdinand. (2023) Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations. American Heart Journal Plus: Cardiology Research and Practice, pages 100350.
Crossref
Crossref
Pierandrea Vinci, Filippo Giorgio Di Girolamo, Emiliano Panizon, Letizia Maria Tosoni, Carla Cerrato, Federica Pellicori, Nicola Altamura, Alessia Pirulli, Michele Zaccari, Chiara Biasinutto, Chiara Roni, Nicola Fiotti, Paolo Schincariol, Alessandro Mangogna & Gianni Biolo. (2023) Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives. International Journal of Environmental Research and Public Health 20:18, pages 6721.
Crossref
Crossref
Zhang Youyou, Jia Ruirui, Wang Hui & Li Zhaoyang. (2023) Association between lipoprotein(a) and ischemic stroke: Fibrinogen as a mediator. Journal of the Neurological Sciences 452, pages 120738.
Crossref
Crossref
Juan M Farina, Chieh-Ju Chao, Milagros Pereyra, Michael Roarke, Ebram F Said, Timothy Barry, Said Alsidawi, Kristen Sell-Dottin, John P Sweeney, David F Fortuin, Chadi Ayoub, Steven J Lester, Jae K Oh, Reza Arsanjani & Francois Marcotte. (2023) Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration. Heart, pages heartjnl-2023-322987.
Crossref
Crossref
Giovanni Cimmino, Francesco Natale, Roberta Alfieri, Luigi Cante, Simona Covino, Rosa Franzese, Mirella Limatola, Luigi Marotta, Riccardo Molinari, Noemi Mollo, Francesco S Loffredo & Paolo Golino. (2023) Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?. Biomedicines 11:9, pages 2353.
Crossref
Crossref
Andreja Rehberger Likozar & Miran Šebeštjen. (2023) Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors. Cardiovascular Ultrasound 21:1.
Crossref
Crossref
Hadi Tabibi & Zahra Yari. (2023) Hyperlipoproteinemia (a) and Phytoestrogen Therapy in Dialysis Patients: A Review. Clinical Therapeutics 45:8, pages e171-e175.
Crossref
Crossref
Mingyang Yang, Basma Nasr, Junzhao Liu, Yu Du & Jiayin Yang. (2023) The association between lipoprotein(a) and atrial fibrillation: A systemic review and meta‐analysis. Clinical Cardiology 46:8, pages 899-905.
Crossref
Crossref
Takahiro Tsushima, Yumiko Tsushima, Claire Sullivan & Betul Hatipoglu. (2023) Lipoprotein(a) and Atherosclerotic Cardiovascular Disease, the Impact of Available Lipid-Lowering Medications on Lipoprotein(a): An Update on New Therapies. Endocrine Practice 29:6, pages 491-497.
Crossref
Crossref
思思 唐. (2023) Correlation between Lipoprotein A and Carotid Atherosclerotic Plaque in Middle-Aged and Elderly Obese Patients. Advances in Clinical Medicine 13:02, pages 2362-2368.
Crossref
Crossref
Anni Wang, Shaojie Zhang, Yayu Li, Fenggui Zhu & Bo Xie. (2023) Study on the relationship between lipoprotein (a) and diabetic kidney disease. Journal of Diabetes and its Complications 37:1, pages 108378.
Crossref
Crossref
Gurpreet Kaur, Snimmer Kaur, Ashif KTK & Jaspreet Kaur. 2023. Green Sustainable Process for Chemical and Environmental Engineering and Science. Green Sustainable Process for Chemical and Environmental Engineering and Science
213
260
.
Zaid N. Safiullah, Thorsten Leucker, Steven R. Jones & Peter P. Toth. 2023. Lipoprotein(a). Lipoprotein(a)
135
158
.
Stamatios Lampsas, Evangelos Oikonomou, Panteleimon Pantelidis, Panagiotis Theofilis, Konstantinos Grammatopoulos, Anastasios Marathonitis, Michael A Vavuranakis, Gerasimos Siasos, Dimitris Tousoulis & Manolis Vavuranakis. (2022) Lipoprotein (a) Levels and Abdominal Aortic Aneurysm. A Systematic Review
and Meta-analysis. Current Pharmaceutical Design 28:43, pages 3492-3499.
Crossref
Crossref
Yan Hao, Yu-lin Yang, Yong-chao Wang & Jian Li. (2022) Effect of the Early Application of Evolocumab on Blood Lipid Profile and Cardiovascular Prognosis in Patients with Extremely High-Risk Acute Coronary Syndrome. International Heart Journal 63:4, pages 669-677.
Crossref
Crossref
Anna Mandel, Andreas Schwarting, Lorenzo Cavagna & Konstantinos Triantafyllias. (2022) Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future. Frontiers in Medicine 9.
Crossref
Crossref
Mark Tomás Mc Auley. (2021) Modeling cholesterol metabolism and atherosclerosis. WIREs Mechanisms of Disease 14:3.
Crossref
Crossref
Hiroshi Yoshida, Yuji Hirowatari, Masatsune Ogura & Mariko Harada‐Shiba. (2021) Current concept and residual issues of lipoprotein(a) determination for a cardiovascular risk factor. European Journal of Clinical Investigation 52:1.
Crossref
Crossref
Sabina Ugovšek & Miran Šebeštjen. (2021) Lipoprotein(a)—The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation. Biomolecules 12:1, pages 26.
Crossref
Crossref
Andreja Rehberger Likozar, Aleš Blinc, Katarina Trebušak Podkrajšek & Miran Šebeštjen. (2021) LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels. Journal of Cardiovascular Development and Disease 8:12, pages 181.
Crossref
Crossref
Tingfeng Wu, Junzhao Ye, Xiaorong Gong, Xin Li, Congxiang Shao, Fuxi Li, Yansong Lin, Qianqian Ma, Weiyi Mai, Wei Wang, Shi-Ting Feng & Bihui Zhong. (2021) Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. Digestive and Liver Disease 53:12, pages 1610-1619.
Crossref
Crossref
Tingfeng Wu, Junzhao Ye, Congxiang Shao, Fuxi Li, Yansong Lin, Qianqian Ma, Wei Wang, Shiting Feng & Bihui Zhong. (2021) Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. Frontiers in Endocrinology 12.
Crossref
Crossref
Joseph Kamtchum-Tatuene, Ali Z. Nomani, Sarina Falcione, Danielle Munsterman, Gina Sykes, Twinkle Joy, Elena Spronk, Maria Isabel Vargas & Glen C. Jickling. (2021) Non-stenotic Carotid Plaques in Embolic Stroke of Unknown Source. Frontiers in Neurology 12.
Crossref
Crossref
Marc P. Bonaca, Naomi M. Hamburg & Mark A. Creager. (2021) Contemporary Medical Management of Peripheral Artery Disease. Circulation Research 128:12, pages 1868-1884.
Crossref
Crossref
Gissette Reyes-Soffer. (2021) The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk. Current Opinion in Lipidology 32:3, pages 163-166.
Crossref
Crossref
Ronald R. NelsonJrJr, Karol Watson & Gissette Reyes-Soffer. 2021. Cardiovascular Disease in Racial and Ethnic Minority Populations. Cardiovascular Disease in Racial and Ethnic Minority Populations
23
28
.